Table 1.
Clinical, laboratory and histological features of SS patients
| ID | Age | Sex | Focus score | Dry mouth | SGE | Saliva vol (ml)/15 min | Low C4 | C4 levels | Anti‐Ro | Anti‐La | RF | ANA | Cryoglobulins | Dry eyes | Arthritis | Raynaud | Palpable purpura | Sclerosing cholangitis | PBC | Interstitial renal disease | Lymphoma |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient 1 | 71 | F | 1·33 | 1 | 0 | 0·250 | 0 | 25·0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Patient 2 | 64 | F | 1·50 | 1 | 1 | 0·115 | 1 | 19·0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Patient 3 | 66 | F | 1·00 | 1 | 0 | 0·120 | 1 | 10·0 | 1 | 0 | 0 | 1 | n.a. | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Patient 4 | 66 | F | 2·22 | 1 | 0 | 1·100 | 0 | 22·4 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Patient 5 | 72 | F | 2·00 | 1 | 0 | 1·100 | 0 | 24·1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Patient 6 | 71 | F | 1·00 | 1 | 1 | 1·700 | 1 | 3·4 | 1 | 1 | 1 | 1 | n.a. | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Patient 7 | 71 | F | 1·00 | 0 | 0 | 1·500 | 1 | 19·0 | 1 | 0 | 0 | 1 | n.a. | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Patient 8 | 53 | F | 1·35 | 1 | 1 | 0·500 | 1 | 14·0 | 0 | 0 | 0 | 0 | n.a. | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Patient 9 | 66 | F | 1·00 | 1 | 1 | 0·100 | 0 | 26·0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
| Patient 10 | 52 | F | 1·71 | 1 | 1 | 0·400 | 1 | 10·0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Patient 11 | 64 | F | 2·40 | 1 | 0 | 2·500 | 1 | 15·8 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Patient 12 | 51 | M | 1·00 | 1 | 0 | 0·500 | 0 | 20·0 | 1 | 1 | n.a. | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Patient 13 | 57 | F | 1·56 | 1 | 0 | 0·300 | 0 | 39·0 | 1 | 1 | 1 | 1 | n.a. | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Patient 14 | 75 | F | 1·09 | 1 | 0 | 0·900 | 1 | 17·0 | 0 | 0 | 0 | 1 | n.a. | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Patient 15 | 67 | F | 1·00 | 1 | 0 | 3·000 | 0 | 24·0 | 1 | 0 | 0 | n.a. | n.a. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Patient 16 | 46 | F | 2·33 | 1 | 0 | 1·200 | 1 | 11·0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
0 = not present/negative; 1 = present/positive; n.a. = data not available; SGE = salivary gland enlargement; RF = rheumatoid factor; ANA = anti‐nuclear antibody; PBC = primary biliary cholangitis; F = female; M = male.